Ashwagandha is not a drug. In the United States, it is classified as a dietary supplement, which means it is sold without a prescription and has not been approved by the FDA to treat, cure, or prevent any disease. That said, ashwagandha is far from pharmacologically inert. Its active compounds interact with brain receptors, lower stress hormones, and shift thyroid function in measurable ways, which is why the question comes up so often.
Why It’s Not Classified as a Drug
The distinction between a drug and a supplement is primarily legal, not chemical. In the U.S., drugs must go through rigorous FDA review for safety and effectiveness before they can be sold. Dietary supplements follow a different path entirely: manufacturers are responsible for evaluating the safety and labeling of their own products before marketing them. The FDA does not review or approve supplements before they reach store shelves.
This looser regulatory framework means ashwagandha products can vary significantly in quality, potency, and purity from one brand to the next. No one checks whether a given capsule actually contains what the label claims before it’s sold to you.
In Europe, the situation is similar but slightly different in language. The European Medicines Agency reviewed ashwagandha as a potential herbal medicinal product but ultimately did not adopt an official monograph for it, meaning it lacks formal recognition as a medicine in the EU as well.
It Acts Like a Drug in Your Body
Even though ashwagandha sits on the supplement shelf, its active compounds, called withanolides, have real pharmacological effects. Lab and animal studies show these compounds interact with several brain systems: they influence the same receptors targeted by anti-anxiety medications (GABA receptors), modulate serotonin receptors, and affect enzymes involved in memory and cognition. That profile looks a lot more like a psychoactive substance than a simple vitamin.
In human trials, ashwagandha consistently lowers cortisol, the body’s primary stress hormone. A 2023 systematic review and meta-analysis published in BJPsych Open found that eight weeks of supplementation produced a statistically significant reduction in both cortisol levels and perceived stress scores compared to placebo. Multiple studies suggest the sweet spot for these effects is 500 to 600 mg per day of a root extract standardized to 5% withanolides.
An international task force formed by the World Federation of Societies of Biological Psychiatry and the Canadian Network for Mood and Anxiety Treatments has gone so far as to provisionally recommend 300 to 600 mg of ashwagandha root extract daily for generalized anxiety disorder. That kind of clinical recommendation is unusual for a supplement and reflects how drug-like its effects can be.
Measurable Effects on Thyroid Hormones
One of the most striking examples of ashwagandha’s pharmacological potency is its impact on thyroid function. In a pilot study of adults with mildly elevated TSH (a marker of underactive thyroid), 600 mg of ashwagandha root extract daily for eight weeks increased levels of the active thyroid hormone T3 by 41.5% and the storage hormone T4 by 19.6%, while significantly lowering TSH.
These are not subtle shifts. For someone with a normally functioning thyroid, or someone already taking thyroid medication, this kind of hormonal change could push levels outside a healthy range. This is one of the clearest reasons ashwagandha deserves the same caution you would give a prescription medication, even though it doesn’t carry that label.
Safety Profile and Liver Concerns
At typical doses, ashwagandha is generally well tolerated. Most clinical trials have used doses between 250 and 600 mg per day of standardized root extract without reporting serious adverse events. However, most of those trials lasted only 8 to 12 weeks, so the long-term safety picture is incomplete.
Liver toxicity has been flagged in a small number of case reports. A 2025 meta-analysis in Frontiers in Nutrition identified nine publications describing potential liver harm associated with ashwagandha, though many of those cases involved confounding factors like pre-existing liver conditions, use of other supplements at the same time, or unusually high doses. In clinical monitoring studies, the liver enzyme elevations that did occur were mild, reversible, and returned to normal after stopping the supplement. Animal research suggests liver damage only occurs at doses far above what humans typically take. Notably, the compounds linked to liver toxicity in the plant do not appear to be concentrated in the root, which is the part most commonly sold as a supplement.
What This Means for You
The fact that ashwagandha is sold as a supplement rather than a drug tells you more about regulatory categories than about what the substance actually does in your body. It lowers cortisol, alters thyroid hormones, and interacts with brain receptors in ways that are biologically significant. Calling it “just a supplement” can create a false sense that it’s as benign as a multivitamin.
If you take thyroid medication, immunosuppressants, or sedatives, the potential for interaction is real. The supplement’s ability to shift hormone levels and influence brain chemistry means it can amplify or interfere with prescription treatments. Product quality also varies widely because no regulatory body verifies what’s inside the capsule before it’s sold. Choosing a product from a brand that uses third-party testing and standardized extracts (like KSM-66, which appears frequently in clinical research) reduces but doesn’t eliminate that uncertainty.